Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03934762Completed
Randomised, double-blind trial in rhabdomyolysis and sterile inflammation, sponsored by University of Thessaly. Primary endpoints: Creatine Kinase at 7 days and Knee Extensor Performance at 7 days. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03934762.